Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca L Grosu

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Frontiers in Oncology|June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate CancerSimon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.
Cancers|July 24, 2021
<sup>18</sup>F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-RadiotherapyMontserrat Carles, Tobias Fechter, Anca L Grosu, et al.
Neuro-Oncology|February 4, 2021
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO groupNorbert Galldiks, Maximilian Niyazi, Anca L Grosu, et al.
Theranostics|May 28, 2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology referenceConstantinos Zamboglou, Montserrat Carles, Tobias Fechter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
[<sup>68</sup>Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancerAlisa S Bettermann, Constantinos Zamboglou, Selina Kiefer, et al.
Radiation Oncology (London, England)|December 2, 2022
<sup>18</sup>F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapyTun Wiltgen, Daniel F Fleischmann, Lena Kaiser, et al.
Neuro-Oncology|June 13, 2017
PET imaging in patients with meningioma-report of the RANO/PET GroupNorbert Galldiks, Nathalie L Albert, Michael Sommerauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2025
A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatmentEleni Gkika, Elke Firat, Sonja Adebahr, et al.
Frontiers in Oncology|December 28, 2020
Comparison of Manual and Semi-Automatic [<sup>18</sup>F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of ReferenceSimon K B Spohn, Maria Kramer, Selina Kiefer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2014
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysisDaniel H Schanne, Ursula Nestle, Michael Allgäuer, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate CancerSimon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.
Cancers|July 24, 2021
<sup>18</sup>F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-RadiotherapyMontserrat Carles, Tobias Fechter, Anca L Grosu, et al.
Neuro-Oncology|February 4, 2021
Contribution of PET imaging to radiotherapy planning and monitoring in glioma patients - a report of the PET/RANO groupNorbert Galldiks, Maximilian Niyazi, Anca L Grosu, et al.
Theranostics|May 28, 2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology referenceConstantinos Zamboglou, Montserrat Carles, Tobias Fechter, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
[<sup>68</sup>Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancerAlisa S Bettermann, Constantinos Zamboglou, Selina Kiefer, et al.
Radiation Oncology (London, England)|December 2, 2022
<sup>18</sup>F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapyTun Wiltgen, Daniel F Fleischmann, Lena Kaiser, et al.
Neuro-Oncology|June 13, 2017
PET imaging in patients with meningioma-report of the RANO/PET GroupNorbert Galldiks, Nathalie L Albert, Michael Sommerauer, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2025
A prospective study of immune responses in patients with lung metastases treated with stereotactic body radiotherapy with or without concurrent systemic treatmentEleni Gkika, Elke Firat, Sonja Adebahr, et al.
Frontiers in Oncology|December 28, 2020
Comparison of Manual and Semi-Automatic [<sup>18</sup>F]PSMA-1007 PET Based Contouring Techniques for Intraprostatic Tumor Delineation in Patients With Primary Prostate Cancer and Validation With Histopathology as Standard of ReferenceSimon K B Spohn, Maria Kramer, Selina Kiefer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2014
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysisDaniel H Schanne, Ursula Nestle, Michael Allgäuer, et al.
Pageof 18